ESCLEROSIS MÚLTIPLE
Publicaciones (177) Publicaciones en las que ha participado algún/a investigador/a
2024
-
Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis
Neurology(R) neuroimmunology & neuroinflammation, Vol. 11, Núm. 4, pp. e200270
-
Bacteria–Fungi Interactions in Multiple Sclerosis
Microorganisms, Vol. 12, Núm. 5
-
Centenarian hippocampus displays high levels of astrocytic metallothioneins
Aging Cell, Vol. 23, Núm. 8
-
Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers?
Translational Neurodegeneration, Vol. 13, Núm. 1
-
Chronic defeat stress induces monoamine level dysregulation in the prefrontal cortex but not in the hippocampus of OF1 male mice
Behavioural Brain Research, Vol. 467
-
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study
Multiple Sclerosis and Related Disorders, Vol. 90
-
Corrigendum to “Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel” [Autoimmunity Reviews, Volume 22, Issue 12, December 2023, 103479] (Autoimmunity Reviews (2023) 22(12), (S1568997223002136), (10.1016/j.autrev.2023.103479))
Autoimmunity Reviews
-
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Journal of neurology, Vol. 271, Núm. 1, pp. 472-485
-
Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study
PLOS Digital Health, Vol. 3, Núm. 7
-
Microbiota modulation by teriflunomide therapy in people with multiple sclerosis: An observational case-control study
Neurotherapeutics, Vol. 21, Núm. 6
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
-
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 95, Núm. 5, pp. 410-418
-
Tetraspanins, GLAST and L1CAM Quantification in Single Extracellular Vesicles from Cerebrospinal Fluid and Serum of People with Multiple Sclerosis
Biomedicines, Vol. 12, Núm. 10
2023
-
Blood RNA-Seq profiling reveals a set of circular RNAs differentially expressed in frail individuals
Immunity and Ageing, Vol. 20, Núm. 1
-
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
JAMA Neurology, Vol. 80, Núm. 7, pp. 702-713
-
Comparative effectiveness in multiple sclerosis: A methodological comparison
Multiple Sclerosis Journal, Vol. 29, Núm. 3, pp. 326-332
-
Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach
Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 9, Núm. 2
-
Disability accrual in primary and secondary progressive multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, Núm. 9, pp. 707-717
-
Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome
Journal of Translational Medicine, Vol. 21, Núm. 1
-
Early biochemical analysis of COVID-19 patients helps severity prediction
PLoS ONE, Vol. 18, Núm. 5 May